STAT
Merck’s heart disease win and the FDA’s new drug regulator
What does Rick Pazdur's new role mean for the FDA? And how much credit can the president take for lowering GLP-1 drug prices?
Merck stakes $9.2B on Cidara and its long-acting flu drug
The deal, one of two multibillion-dollar buyouts from Merck this year, centers around a drug that could become an alternative ...
Blockonomi
Merck (MRK) Stock: Heart Drug Trial Results Push Shares Up
Shares rise 8.5% on enlicitide decanoate Phase 3 data showing LDL reduction. Q3 earnings beat at $2.58/share with $17.3B ...
Merck sees over $5 billion opportunity in Cidara's experimental flu drug
Merck said on Monday it expects a non-risk adjusted commercial opportunity in excess of $5 billion from Cidara Therapeutics' ...
BioWorld
Merck buys Cidara for $9.2B as Keytruda patent loss looms
Merck & Co. Inc. is buying Cidara Therapeutics Inc. for $9.2 billion to acquire a late-stage flu candidate and also to outrace blockbuster Keytruda’s looming patent expiration. CD-388, Cidara’s lead ...